HEAL Stock Overview
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$7.28 |
| 52 Week High | US$7.81 |
| 52 Week Low | US$6.05 |
| Beta | 0 |
| 1 Month Change | -4.50% |
| 3 Month Change | -0.30% |
| 1 Year Change | -1.95% |
| 3 Year Change | -30.57% |
| 5 Year Change | 15.49% |
| Change since IPO | 45.52% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| HEAL | CH Capital Markets | CH Market | |
|---|---|---|---|
| 7D | 2.0% | 0.4% | 2.0% |
| 1Y | -2.0% | 31.0% | -2.8% |
Return vs Industry: HEAL underperformed the Swiss Capital Markets industry which returned 31% over the past year.
Return vs Market: HEAL matched the Swiss Market which returned -2.8% over the past year.
Price Volatility
| HEAL volatility | |
|---|---|
| HEAL Average Weekly Movement | 2.0% |
| Capital Markets Industry Average Movement | 3.2% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.3% |
| 10% least volatile stocks in CH Market | 1.9% |
Stable Share Price: HEAL has not had significant price volatility in the past 3 months.
Volatility Over Time: HEAL's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2016 | n/a | n/a | www.ishares.com/uk/institutional/en/products/284216/HEAL |
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF is an exchange traded fund launched by BlackRock Asset Management Ireland Limited. The fund is managed by BlackRock Advisors (UK) Limited. It invests in public equity markets across the globe.
iShares IV Public Limited Company - iShares Healthcare Innovation UCITS ETF Fundamentals Summary
| HEAL fundamental statistics | |
|---|---|
| Market cap | US$1.05b |
| Earnings (TTM) | US$0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs HEAL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HEAL income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$0 |
| Earnings | US$0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did HEAL perform over the long term?
See historical performance and comparison